Related references
Note: Only part of the references are listed.Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease
Yueyao Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
Lei Shu et al.
STEM CELL RESEARCH & THERAPY (2020)
IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
Zhengjuan Lu et al.
FRONTIERS IN NEUROLOGY (2020)
Inhibiting hydrogen sulfide production in umbilical stem cells reduces their protective effects during experimental necrotizing enterocolitis
Natalie A. Drucker et al.
JOURNAL OF PEDIATRIC SURGERY (2019)
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
Guido Moll et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial
Woo-Suk Lee et al.
STEM CELLS TRANSLATIONAL MEDICINE (2019)
Mesenchymal stem cells promote mesenteric vasodilation through hydrogen sulfide and endothelial nitric oxide
Jan Te Winkel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels
Neil H. Riordan et al.
STEM CELLS TRANSLATIONAL MEDICINE (2019)
Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes
Lorena R. Braid et al.
CYTOTHERAPY (2018)
Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical Trial
Jian Zhang et al.
GUT AND LIVER (2018)
The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice
Yaqi Yin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges
Luiza Bagno et al.
MOLECULAR THERAPY (2018)
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Yufang Shi et al.
NATURE REVIEWS NEPHROLOGY (2018)
Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase la Clinical Trial
Eun Hye Park et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up
Xiaohua Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
Jay S. Skyler et al.
DIABETES CARE (2015)
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
Courtney Premer et al.
EBIOMEDICINE (2015)
Mesenchymal Stem Cells Ameliorate Atherosclerotic Lesions via Restoring Endothelial Function
Yu-Ling Lin et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis
Annelies Bronckaers et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study
Ranhua Jiang et al.
Frontiers of Medicine (2011)
Endothelial dysfunction and vascular disease
P. M. Vanhoutte et al.
ACTA PHYSIOLOGICA (2009)
Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres
P Windrum et al.
BONE MARROW TRANSPLANTATION (2005)
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction
DL Kraitchman et al.
CIRCULATION (2005)
Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome
JG Wang et al.
HYPERTENSION (2005)
Blood pressure and stroke - An overview of published reviews (vol 35, pg 776, 2004)
CMM Lawes et al.
STROKE (2004)
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy
JL Spees et al.
MOLECULAR THERAPY (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution
IM Barbash et al.
CIRCULATION (2003)
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects
LA Ortiz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release
C Haug et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
Share Paper
